Blog

AUSTRALIAN DRUG DEVELOPMENT BLOG

Australia Gains Further Traction in Early and Mid-Stage Clinical Trial Research Market

Recent Report Shows Australia Rising to 3rd in Number of Industry-Initiated Phase I Clinical Trials in 2021

The Association of the British Pharmaceutical Industry, which is the UK’s equivalent to Medicines Australia, recently issued a report concluding, “Pharmaceutical companies are increasingly placing their trials in other countries (e.g., Australia and Spain).”
Australia Gains Drug Development Market Share